Welcome to the European Society for Medical Oncology (ESMO), the leading European professional organization representing medical oncologists. more about ESMO ...
ESMO FAMILY SITES
ESMO NEWS
- 17.01.12 - Young Oncologists' Journal Club - latest article
Bevacizumab in the Primary Treatment of Advanced Ovarian Cancer
- 16.01.12 - The latest E-Learning module is now available online:
Anxiety and Depression in Cancer Patients by Prof. Maria Die Trill
- 09.01.12 - Read the latest Journal Club article:
Overcoming endocrine resistance in advanced breast cancer by inhibiting the mTOR pathway by...
- 06.01.12 - Recognition of Excellence in Oncology: nominate your candidate/s!
Do you know anyone who has made an exceptional contribution to medical oncology? Nominate them for...
- 20.12.11 - ESMO 's thoughts are with the Italian medical oncology community for the loss of the AIOM President
Marco Venturini, a passionate and visionary oncologist very active in Italy and at the European...
[more...]
SCIENTIFIC NEWS
- 27.01.12 - Next-generation proteasome blockers promise safer cancer therapy
Small mechanistic differences to translate into different therapeutic effects
- 26.01.12 - Researchers expose molecular connection between inflammation and DNA methylation in the development of colorectal cancer
Inflammatory mediator promotes colorectal cancer by stifling protective genes
- 25.01.12 - Younger breast cancer patients have more adverse quality of life issues
Decrease in health-related quality of life associated with increased psychological distress, weight...
- 25.01.12 - Researchers identified a cause of resistance to colon cancer treatment with cetuximab
A completely new mechanism of resistance discovered to a drug used very often for a type of cancer...
- 23.01.12 - European Medicines Agency issues recommendations for healthcare professionals to prevent administration errors with bortezomib
Meeting highlights from the Committee for Medicinal Products for Human Use (16-19 Jan 2012)
[more...]
Membership
Journal Club Latest article
OncologyPRO
ESMO Fellowship program
